SCOPUS 정보 검색 플랫폼

Volumn 20, Issue 2, 2014, Pages

Acquired haemophilia A after stem cell transplant for sickle cell disease: Treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone

(8) Lozier, J N a Nghiem, K a Lee, M b Hodsdon, B a Joe, G a Weitzel, R P c Tisdale, J F c Hsieh, M c

a NATIONAL INSTITUTES OF HEALTH (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c NATIONAL HEART LUNG AND BLOOD INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANEMIA, SICKLE CELL; ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; FACTOR VIII; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHILIA A; HUMANS; IMMUNOGLOBULIN G; MALE; PREDNISONE;

EID: 84894107180 PISSN: 13518216 EISSN: 13652516 Source Type: Journal
DOI: 10.1111/hae.12372 Document Type: Letter

Times cited : (11)

References (8)

1
- 71849118976
- Allogeneic hematopoietic stem-cell transplantation for sickle cell disease
- Hsieh MM, Kang EM, Fitzhugh CD, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009; 361: 2309-17.
- (2009) N Engl J Med , vol.361 , pp. 2309-2317
- Hsieh, M.M.¹ Kang, E.M.² Fitzhugh, C.D.³

2
- 0027159230
- The treatment of acquired fctor VIII inhibitors: Worldwide experience with porcine factor VIII concentrate
- for the International Acquired Hemophilia Study Group.
- Kessler CM, Ludlam CA, for the International Acquired Hemophilia Study Group. The treatment of acquired fctor VIII inhibitors: Worldwide experience with porcine factor VIII concentrate. Semin Hematol 1993; 30: 22-7.
- (1993) Semin Hematol , vol.30 , pp. 22-27
- Kessler, C.M.¹ Ludlam, C.A.²

3
- 0027405692
- Use of porcine factor VIII in the treatment of patients with acquired hemophilia
- Morrison AI, Ludlam CA, Kessler C. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993; 81: 1513-20.
- (1993) Blood , vol.81 , pp. 1513-1520
- Morrison, A.I.¹ Ludlam, C.A.² Kessler, C.³

4
- 84873583409
- Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
- Whelan SFJ, Hofbauer CJ, Horling FM, et al. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients. Blood 2012; 121: 1039-48.
- (2012) Blood , vol.121 , pp. 1039-1048
- Whelan, S.F.J.¹ Hofbauer, C.J.² Horling, F.M.³

5
- 63849118538
- Quantitation of anti-factor VIII antibodies in human plasma
- Krudysz-Amblo J, Parhami-Seren B, Butenas S, et al. Quantitation of anti-factor VIII antibodies in human plasma. Blood 2009; 113: 2587-94.
- (2009) Blood , vol.113 , pp. 2587-2594
- Krudysz-Amblo, J.¹ Parhami-Seren, B.² Butenas, S.³

6
- 0026576594
- Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals
- Algiman M, Dietrich G, Nydegger UE, Boieldieu D, Sultan Y, Kazatchkine MD. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci USA 1992; 89: 3795-9.
- (1992) Proc Natl Acad Sci USA , vol.89 , pp. 3795-3799
- Algiman, M.¹ Dietrich, G.² Nydegger, U.E.³ Boieldieu, D.⁴ Sultan, Y.⁵ Kazatchkine, M.D.⁶

7
- 77951632334
- Acquired haemophilia caused by non-haemophilic factor VIII gene variants
- Tiede A, Eisert R, Czwalinna A, Miesbach W, Scharrer I, Ganser A. Acquired haemophilia caused by non-haemophilic factor VIII gene variants. Ann Hematol 2010; 89: 607-12.
- (2010) Ann Hematol , vol.89 , pp. 607-612
- Tiede, A.¹ Eisert, R.² Czwalinna, A.³ Miesbach, W.⁴ Scharrer, I.⁵ Ganser, A.⁶

8
- 64749096663
- Inhibitors of factor VIII in black patients with hemophilia
- Viel KR, Ameri A, Abshire TC, et al. Inhibitors of factor VIII in black patients with hemophilia. N Engl J Med 2009; 360: 1618-27.
- (2009) N Engl J Med , vol.360 , pp. 1618-1627
- Viel, K.R.¹ Ameri, A.² Abshire, T.C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.